Candel Therapeutics CADL
$8.75 +$0.71 (+8.83%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $8.83 +0.91%
Open$8.24
Prev close$8.04
Day range$8.06 – $8.75
Volume955.0K
Market cap$669.54M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q2, ended Jun 2026
Revenue$0.00
Operating profit-$26.72M-139.1% YoY
Net profit-$38.91M-711.2% YoY
Diluted EPS-$0.52-477.8% YoY
Free cash flow-$17.25M-93.4% YoY
Operating cash flow-$17.18M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Return on equity-81.8%
Return on assets-56.4%
Return on invested capital-64.8%
Current ratio16.09
Liabilities / assets39.4%
Cash & investments$201.57M
Total debt$49.06M
Net cash (debt)$152.51M
Income statement
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $26.72M | $16.26M | $48.18M | $15.66M | $13.21M |
| Selling and Admin Expenses | $6.95M | $6.44M | $17.77M | $4.72M | $4.75M |
| -General & Admin Expense | $6.95M | $6.44M | $17.77M | $4.72M | $4.75M |
| Research & Development | $19.80M | $9.84M | $30.50M | $11.03M | $8.46M |
| Other Operating Expenses | -$22,000.00 | -$22,000.00 | -$89,000.00 | – | – |
| Operating Profit | -$26.72M | -$16.26M | -$48.18M | -$15.66M | -$13.21M |
| Net Non-Operating Interest Income (Expense) | $97,000.00 | -$242,000.00 | $1.80M | -$314,000.00 | $792,000.00 |
| Non-Operating Interest Income | $1.67M | $1.32M | $3.92M | $1.10M | $953,000.00 |
| Non-Operating Interest Expense | $1.58M | $1.56M | $2.12M | $1.42M | $161,000.00 |
| Other Income (Expense) | -$12.28M | $7.64M | $8.20M | -$13.52M | $1.15M |
| Gain on Sale of Security | -$12.28M | $7.64M | $8.20M | -$13.52M | $1.15M |
| Pretax Profit | -$38.91M | -$8.86M | -$38.18M | -$29.50M | -$11.27M |
| Net Profit | -$38.91M | -$8.86M | -$38.18M | -$29.50M | -$11.27M |
| Profit from Continuing Operations | -$38.91M | -$8.86M | -$38.18M | -$29.50M | -$11.27M |
| Net Income to Parent Company | -$38.91M | -$8.86M | -$38.18M | -$29.50M | -$11.27M |
| Net Income to Common Stockholders | -$38.91M | -$8.86M | -$38.18M | -$29.50M | -$11.27M |
| Basic EPS | -$0.52 | -$0.14 | -$0.72 | -$0.54 | -$0.21 |
| Diluted EPS | -$0.52 | -$0.14 | -$0.72 | -$0.54 | -$0.21 |
Balance sheet
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $208.15M | $201.92M | $125.20M | $125.20M | $93.60M |
| Total Current Assets | $204.16M | $197.75M | $121.39M | $121.39M | $90.13M |
| Cash and Cash Equivalents & Short-Term Investments | $201.57M | $194.83M | $119.73M | $119.73M | $86.96M |
| -Cash and Cash Equivalents | $201.57M | $194.83M | $119.73M | $119.73M | $86.96M |
| Other Current Assets | $2.59M | $2.92M | $1.66M | $1.66M | $3.17M |
| Total Non-Current Assets | $3.99M | $4.17M | $3.81M | $3.81M | $3.46M |
| Net PPE | $3.48M | $3.64M | $3.30M | $3.30M | $3.11M |
| -Gross PPE | $7.35M | $7.35M | $6.86M | $6.86M | $6.54M |
| -Accumulated Depreciation | -$3.87M | -$3.70M | -$3.56M | -$3.56M | -$3.43M |
| Other Non-Current Assets | $514,000.00 | $524,000.00 | $503,000.00 | $503,000.00 | $351,000.00 |
| Total Liabilities | $82.02M | $63.89M | $73.27M | $73.27M | $13.47M |
| Total Current Liabilities | $12.69M | $7.05M | $9.00M | $9.00M | $10.93M |
| Payables | $5.15M | $3.04M | $1.13M | $1.13M | $1.12M |
| -Accounts Payable | $5.15M | $3.04M | $1.13M | $1.13M | $1.12M |
| Current Accrued Expenses | $6.98M | $3.47M | $7.33M | $7.33M | $5.15M |
| Short-Term Debt and Capital Lease Obligation | $461,000.00 | $453,000.00 | $445,000.00 | $445,000.00 | $4.66M |
| -Current Capital Lease Obligation | $461,000.00 | $453,000.00 | $445,000.00 | $445,000.00 | $437,000.00 |
| Other Current Liabilities | $89,000.00 | $89,000.00 | $89,000.00 | $89,000.00 | – |
| Total Non-Current Liabilities | $69.33M | $56.84M | $64.28M | $64.28M | $2.55M |
| Long Term Debt and Capital Lease Obligation | $49.06M | $48.82M | $48.59M | $48.59M | $2.55M |
| -Long Term Debt | $47.83M | $47.48M | $47.13M | $47.13M | $973,000.00 |
| -Long Term Capital Lease Obligation | $1.23M | $1.34M | $1.46M | $1.46M | $1.57M |
| Derivative Product Liabilities | $20.23M | $7.96M | $15.60M | $15.60M | – |
| Non-Current Deferred Liabilities | $45,000.00 | $67,000.00 | $89,000.00 | $89,000.00 | – |
| Total Equity | $126.13M | $138.03M | $51.92M | $51.92M | $80.12M |
| Stockholders' Equity | $126.13M | $138.03M | $51.92M | $51.92M | $80.12M |
| Capital Stock | $761,000.00 | $733,000.00 | $550,000.00 | $550,000.00 | $550,000.00 |
| -Common Stock | $761,000.00 | $733,000.00 | $550,000.00 | $550,000.00 | $550,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $403.97M | $376.99M | $282.21M | $282.21M | $280.91M |
| Retained Earnings | -$278.15M | -$239.25M | -$230.39M | -$230.39M | -$200.89M |
| Less: Treasury Stock | $448,000.00 | $448,000.00 | $448,000.00 | $448,000.00 | $448,000.00 |
| -Current Debt | – | – | – | – | $4.23M |
Cash flow
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$17.18M | -$18.04M | -$38.31M | -$10.57M | -$10.24M |
| Net cash flow from continuing operations | -$17.18M | -$18.04M | -$38.31M | -$10.57M | -$10.24M |
| Net Income from Continuing Operations | -$38.91M | -$8.86M | -$38.18M | -$29.50M | -$11.27M |
| Gain/Loss from Continuing Operations | $12.28M | -$7.64M | -$7.89M | $13.49M | -$818,000.00 |
| Depreciation & Depletion & Amortization | $171,000.00 | $149,000.00 | $845,000.00 | $163,000.00 | $195,000.00 |
| Other Non-Cash Items | $450,000.00 | $437,000.00 | $819,000.00 | $387,000.00 | $136,000.00 |
| Change in Working Capital | $5.97M | -$3.57M | $2.19M | $3.60M | $356,000.00 |
| -Change in Prepaid Assets | $192,000.00 | -$1.26M | -$508,000.00 | $1.20M | $61,000.00 |
| -Change in Payables and Accrued Expense | $5.90M | -$2.16M | $3.06M | $2.32M | $464,000.00 |
| -Change in Other Current Assets | $10,000.00 | -$21,000.00 | -$24,000.00 | -$2,000.00 | -$40,000.00 |
| -Change in Other Current Liabilities | -$110,000.00 | -$108,000.00 | -$509,000.00 | -$105,000.00 | -$129,000.00 |
| -Change In Other Working Capital | -$22,000.00 | -$22,000.00 | $178,000.00 | – | – |
| Net cash flow from investing | -$69,000.00 | -$675,000.00 | -$560,000.00 | -$409,000.00 | -$117,000.00 |
| Net Cash Flow from Continuing Investing Activities | -$69,000.00 | -$675,000.00 | -$560,000.00 | -$409,000.00 | -$117,000.00 |
| Net PPE Purchase and Sale | -$69,000.00 | -$675,000.00 | -$560,000.00 | -$409,000.00 | -$117,000.00 |
| Financing Cash Flow | $23.98M | $93.82M | $56.10M | $43.90M | -$3.37M |
| Net Cash Flow from Continuing Financing Activities | $23.98M | $93.82M | $56.10M | $43.90M | -$3.37M |
| Net Issuance Payments Of Debt | $0.00 | $0.00 | $36.21M | $43.71M | -$2.50M |
| Net Common Stock Issuance | $23.95M | $93.79M | $19.37M | $0.00 | -$713,000.00 |
| Proceeds from Stock Option Exercised | $31,000.00 | $28,000.00 | $516,000.00 | $4,000.00 | $20,000.00 |
| Ending Cash Balance | $201.98M | $195.25M | $120.15M | $120.15M | $87.23M |
| Net Change in Cash | $6.73M | $75.10M | $17.23M | $32.92M | -$13.72M |
| Beginning Cash Balance | $195.25M | $120.15M | $102.92M | $87.23M | $100.95M |
| Free Cash Flow | -$17.25M | -$18.71M | -$38.90M | -$10.98M | -$10.38M |
No comments yet — be the first to weigh in on CADL.
Sign in to join the discussion.